DRTS vs. ABCL
DRTS (Alpha Tau Medical Ltd) and ABCL (AbCellera Biologics Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, DRTS returned 4.51%/yr vs -17.32%/yr for ABCL. At a 0.10 correlation, their price movements are largely independent.
Performance
DRTS vs. ABCL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, DRTS achieves a 146.06% return, which is significantly higher than ABCL's 90.64% return.
DRTS
- 1D
- -4.17%
- 1M
- 23.65%
- 6M
- 71.79%
- YTD
- 146.06%
- 1Y
- 298.04%
- 3Y*
- 44.70%
- 5Y*
- 4.51%
- 10Y*
- —
ABCL
- 1D
- -4.12%
- 1M
- 24.43%
- 6M
- 44.25%
- YTD
- 90.64%
- 1Y
- 62.59%
- 3Y*
- -3.07%
- 5Y*
- -17.32%
- 10Y*
- —
DRTS vs. ABCL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
DRTS Alpha Tau Medical Ltd | 146.06% | 59.68% | 2.99% | -5.35% | -67.62% | -2.77% |
ABCL AbCellera Biologics Inc. | 90.64% | 16.72% | -48.69% | -43.63% | -29.16% | -50.02% |
Correlation
The correlation between DRTS and ABCL is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Mar 8, 2021 | 0.10 |
Over the past year, DRTS and ABCL have become more correlated (0.33) than their long-term average of 0.10, meaning their price movements have been converging.
Fundamentals
DRTS:
$1.10B
ABCL:
$1.99B
DRTS:
-$0.65
ABCL:
-$0.48
DRTS:
15.75
ABCL:
2.11
DRTS:
$0.00
ABCL:
$79.21M
DRTS:
$0.00
ABCL:
$70.89M
DRTS:
-$45.55M
ABCL:
-$166.07M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DRTS vs. ABCL — Risk / Return Rank
DRTS
ABCL
DRTS vs. ABCL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alpha Tau Medical Ltd (DRTS) and AbCellera Biologics Inc. (ABCL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| DRTS | ABCL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.13 | ||
| Sortino ratioReturn per unit of downside risk | +2.23 | ||
| Omega ratioGain probability vs. loss probability | 1.47 | 1.18 | +0.29 |
| Calmar ratioReturn relative to maximum drawdown | 12.58 | 1.15 | +11.43 |
| Martin ratioReturn relative to average drawdown | 30.20 | 2.07 | +28.13 |
Loading charts...
Drawdowns
DRTS vs. ABCL - Drawdown Comparison
The maximum DRTS drawdown since its inception was -86.86%, smaller than the maximum ABCL drawdown of -96.84%. Use the drawdown chart below to compare losses from any high point for DRTS and ABCL.
Loading charts...
Drawdown Indicators
| DRTS | ABCL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.86% | -96.84% | +9.98% |
Max Drawdown (1Y)Largest decline over 1 year | -23.87% | -54.94% | +31.07% |
Max Drawdown (3Y)Largest decline over 3 years | -52.59% | -75.72% | +23.13% |
Max Drawdown (5Y)Largest decline over 5 years | -86.86% | -90.96% | +4.10% |
Current DrawdownCurrent decline from peak | -20.39% | -89.31% | +68.92% |
Average DrawdownAverage peak-to-trough decline | -56.92% | -84.20% | +27.28% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.92% | 30.29% | -20.37% |
Volatility
DRTS vs. ABCL - Volatility Comparison
The current volatility for Alpha Tau Medical Ltd (DRTS) is 20.03%, while AbCellera Biologics Inc. (ABCL) has a volatility of 25.44%. This indicates that DRTS experiences smaller price fluctuations and is considered to be less risky than ABCL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DRTS | ABCL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 20.03% | 25.44% | -5.41% |
Volatility (6M)Calculated over the trailing 6-month period | 60.77% | 57.96% | +2.81% |
Volatility (1Y)Calculated over the trailing 1-year period | 76.67% | 79.28% | -2.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 79.49% | 67.47% | +12.02% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 76.85% | 70.67% | +6.18% |
Dividends
DRTS vs. ABCL - Dividend Comparison
Neither DRTS nor ABCL has paid dividends to shareholders.
Financials
DRTS vs. ABCL - Financials Comparison
This section allows you to compare key financial metrics between Alpha Tau Medical Ltd and AbCellera Biologics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
DRTS and ABCL have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABCL has higher volatility (25.44%) compared to DRTS (20.03%). In terms of maximum drawdown, DRTS dropped -86.86% vs ABCL's -96.84%.
DRTS currently has the higher Sharpe Ratio (3.92 vs 0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for DRTS and ABCL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer